230
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Phenotypic Drug Resistance Pattern and Mutation Characteristics of Mycobacterium tuberculosis from Different Body Fluids Among Extra Pulmonary Patients Presented in Selected Hospitals in Addis Ababa, Ethiopia

, , , , , , , , , , ORCID Icon, , , & show all
Pages 5511-5522 | Received 06 Apr 2023, Accepted 11 Aug 2023, Published online: 22 Aug 2023

References

  • Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241. doi:10.1177/2042098614554919
  • Iacobino A, Fattorini L, Giannoni F. Drug-Resistant Tuberculosis 2020: where We Stand. Appl Sci. 2020;10:1–17.
  • Wang DM, Feng LQ, Zhu M, Xu YH, Liao Y. Clinical characteristics, common sites and drug resistance profile in culture-confirmed extrapulmonary TB/HIV co-infection patients, Southwest China. J Glob Antimicrob Resist. 2022;28:1–7. doi:10.1016/j.jgar.2021.10.028
  • Otu J, Gehre F, Zingue D, et al. Multidrug-Resistant Tuberculosis (Mdr-Tb): an Emerging Problem in West Africa. BMJ Glob Heal. 2017;2:A32.3–A33. doi:10.1136/bmjgh-2016-000260.85
  • Prasad R, Gupta N, Singh M. Multidrug resistant tuberculosis: trends and control. Indian J Chest Dis Allied Sci. 2014;56:237–246.
  • Lange CH, Chesov DU, Heyckendorf JAN, Leung CHIC. Invited Review Series: Tuberculosis Updates 2018. Drug-Resistant Tuberculosis. 2018:656. doi:10.1111/resp.13304
  • Singh PK. Epidemiological perspective of drug resistant extrapulmonary tuberculosis. World J Clin Infect Dis. 2015;5:77. doi:10.5495/wjcid.v5.i4.77
  • Gambhir S, Ravina M, Rangan K, Dixit M, Barai S. Imaging in extrapulmonary tuberculosis. Int J Infect Dis. 2017;56:237–247. doi:10.1016/j.ijid.2016.11.003
  • Schön T, Miotto P, Köser CU, Viveiros M, Böttger E, Cambau E. Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives. Clin Microbiol Infect. 2017;23:154–160. doi:10.1016/j.cmi.2016.10.022
  • Dusthackeer A, Sekar G, Chidambaram S, Kumar V, Mehta P, Swaminathan S. Drug resistance among extrapulmonary TB patients: six years experience from a supranational reference laboratory. Indian J Med Res. 2015;142:568–574. doi:10.4103/0971-5916.171284
  • Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D. Mycobacteriology Laboratory Manual. J Clin Microbiol. 2014;37:3578–3582. doi:10.1128/jcm.37.11.3578-3582.1999
  • Yousif N, Cole J, Rothwell JC, et al. Technical Manual for Drug Susceptibility Testing of Medicines Used in the Treatment of Tuberculosis. Vol. 9. World Health Organization; 2018.
  • Armstrong D. Hain genotype line probe assay: overview and training. Int J Med. 2018;17.
  • Cucunawangsih WV, Widysanto A, Lugito NPH. Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area. Int J Mycobacteriol. 2015;4:302–305. doi:10.1016/j.ijmyco.2015.08.002
  • Walls G, Bulifon S, Breysse S, et al. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia. Glob Health Action. 2015;8:2–10. doi:10.3402/gha.v8.25964
  • Maurya AK, Kant S, Kushwaha RAS, Dhole T, Nag VL. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India. J Postgrad Med. 2012;58:185–189. doi:10.4103/0022-3859.101379
  • Addo SO, Mensah GI, Mosi L, Abrahams AOD, Addo KK. Genetic diversity and drug resistance profiles of Mycobacterium tuberculosis complex isolates from patients with extrapulmonary tuberculosis in Ghana and their associated host immune responses. IJID Reg. 2022;4:75–84. doi:10.1016/j.ijregi.2022.06.005
  • Ali M, Howady F, Munir W, et al. Drug-resistant tuberculosis: an experience from Qatar. Libyan J Med. 2020:15. doi:10.1080/19932820.2020.1744351
  • Getu D, Kebede A, Habteyes Hailu Tol BY. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia. PLoS One. 2020;29:1–13. doi:10.1371/journal.pone.0243493
  • Diriba G, Kebede A, Tola HH, et al. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia. Infect Dis Poverty. 2019;8:4–9. doi:10.1186/s40249-019-0554-4
  • Zewdie O, Mihret A, Abebe T, et al. Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa. New Microbes New Infect. 2018;21:36–41. doi:10.1016/j.nmni.2017.10.009
  • Diriba G, Kebede A, Tola HH, et al. Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. SAGE Open Med. 2022;10:205031212210982. doi:10.1177/20503121221098241
  • Gygli SM, Borrell S, Trauner A, Gagneux S. Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev. 2017;41:354–373. doi:10.1093/femsre/fux011